Background For patients with smoldering multiple myeloma, the standard of care is
observation until symptoms develop. However, this approach does not identify high-risk …

Multiple myeloma (MM) is a clinical disorder characterized by aberrant plasma cell growth in
the bone marrow microenvironment. Globally, the prevalence of MM has been steadily …

Monoclonal gammopathy of unknown significance (MGUS), smouldering multiple myeloma
(SMM), and multiple myeloma (MM) are very common neoplasms. However, it is often …

多发性骨髓瘤(multiplemyeloma, MM) 是常见的造血系统恶性肿瘤, 其发病率在我国血液肿瘤中
位居第2 位, 特征为骨髓克隆浆细胞异常增殖. 随着新药的应用, MM 的治疗取得重大进展 …

This article presents an evaluation of spine segmentation models using clinical data
obtained from multiple myeloma patients. The performance of the models is compared …

Multiple myeloma (MM) is a common malignant tumor of the hematopoietic system,
characterized by abnormal proliferation of bone marrow clonal plasma cells. The incidence …

A cancer is one that develops due to uncontrolled proliferation of cells in the body. While
some cancers hijack the bodies at such jaw-dropping speeds that it becomes difficult to …

Multiple myeloma is the second most common hematologic malignancy, accounting for 10%
of all cases (Rajkumar, 2016). Multiple myeloma is described as an increase in clonal …

抄録 プロテアソーム阻害剤や免疫調節薬, 抗体薬など新規治療薬の導入により,
多発性骨髄腫の治療成績は目覚ましい進歩を遂げている. 移植適応初発骨髄腫の現在の標準治療 …